trending Market Intelligence /marketintelligence/en/news-insights/trending/5YhOBtNgxl8k6LP1Xm0P8w2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Vaccine-maker CanSino Biologics plans to list on China's Starboard exchange

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Vaccine-maker CanSino Biologics plans to list on China's Starboard exchange

Chinese vaccine-maker CanSino Biologics Inc. is planning to list on Shanghai's Starboard Exchange, Bloomberg News reported.

The Tianjin-based company, which went public on the Hong Kong Stock Exchange in March, is planning to issue up to 24.8 million A shares on Starboard.

Starboard is seen as China's answer to the Hong Kong Stock Excahnge, which relaxed rules for pre-revenue companies in 2018 to list on the exchange. Starboard, which is hosted by the Shanghai Stock Exchange, is the first board in China to enable pre-profit, high-tech startups and companies with dual-class shareholding structures to conduct IPOs and be traded publicly.

CanSino — whose Ebola vaccine Ad5-EBOV was approved in China for emergency use and for national stockpiling purposes — said in March that it was planning to release two vaccines for a deadly brain and spinal cord infection called meningitis in the Asian country.